| FDA approves everolimus for treatment of kidney angiomyolipomas associated with tuberous sclerosis. |
|
| FDA: The U.S. Food and Drug Administration today approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex (TSC). |